Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIG<i>MS</i>study

202044 citationsJournal Articlehybrid Open Access

Authors

Fingolimod significantly reduced MRI activity and ARBA for up to 2 years versus IFN β-1a in PoMS.

Published in: Journal of Neurology Neurosurgery & Psychiatry

Volume 91, Issue 5, pp. 483-492

Field-Weighted Citation Impact: 3.48